Illumina Posts Higher 1Q Profit, Sales, Citing Growing Demand for NovaSeq X

Dow Jones

05/01

By Paul Ziobro

Illumina posted higher profit and sales in the first quarter, citing rising demand for its gene-sequencing machines.

The genomics company on Thursday reported a profit of $134 million, or 87 cents a share, compared with $131 million, or 82 cents, in the same quarter a year ago.

Adjusted earnings came in at $1.15 a share. Analysts polled by Factset expected $1.05 a share.

Revenue rose 4.8% to $1.09 billion, ahead of the $1.07 million expected by analysts.

Chief Executive Jacob Thaysen said that demand for its NovaSeq X machine is increasing as the company helps its clinical customers expand into new application areas.

With the strong start to the year, Illumina bumped up its guidance. It now expects revenue between $4.52 billion and $4.62 billion, up $20 million at the midpoint versus its prior guidance.

It now forecasts adjusted per-share earnings between $5.15 and $5.30, up from $5.05 to $5.20.

Write to Paul Ziobro at paul.ziobro@wsj.com

(END) Dow Jones Newswires

April 30, 2026 16:05 ET (20:05 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2632651206"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2632651206\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2632651206?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-01 04:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632651206","market":"nz","top_or_hot":-1,"title":"Illumina Posts Higher 1Q Profit, Sales, Citing Growing Demand for NovaSeq X","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Paul Ziobro \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ILMN\">Illumina</a> posted higher profit and sales in the first quarter, citing rising demand for its gene-sequencing machines. \n</p>\n<p>\n  The genomics company on Thursday reported a profit of $134 million, or 87 cents a share, compared with $131 million, or 82 cents, in the same quarter a year ago. \n</p>\n<p>\n  Adjusted earnings came in at $1.15 a share. Analysts polled by Factset expected $1.05 a share. \n</p>\n<p>\n  Revenue rose 4.8% to $1.09 billion, ahead of the $1.07 million expected by analysts. \n</p>\n<p>\n  Chief Executive Jacob Thaysen said that demand for its NovaSeq X machine is increasing as the company helps its clinical customers expand into new application areas. \n</p>\n<p>\n  With the strong start to the year, Illumina bumped up its guidance. It now expects revenue between $4.52 billion and $4.62 billion, up $20 million at the midpoint versus its prior guidance. \n</p>\n<p>\n  It now forecasts adjusted per-share earnings between $5.15 and $5.30, up from $5.05 to $5.20. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Paul Ziobro at paul.ziobro@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 30, 2026 16:05 ET (20:05 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Illumina Posts Higher 1Q Profit, Sales, Citing Growing Demand for NovaSeq X</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIllumina Posts Higher 1Q Profit, Sales, Citing Growing Demand for NovaSeq X\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-01 04:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Paul Ziobro \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ILMN\">Illumina</a> posted higher profit and sales in the first quarter, citing rising demand for its gene-sequencing machines. \n</p>\n<p>\n  The genomics company on Thursday reported a profit of $134 million, or 87 cents a share, compared with $131 million, or 82 cents, in the same quarter a year ago. \n</p>\n<p>\n  Adjusted earnings came in at $1.15 a share. Analysts polled by Factset expected $1.05 a share. \n</p>\n<p>\n  Revenue rose 4.8% to $1.09 billion, ahead of the $1.07 million expected by analysts. \n</p>\n<p>\n  Chief Executive Jacob Thaysen said that demand for its NovaSeq X machine is increasing as the company helps its clinical customers expand into new application areas. \n</p>\n<p>\n  With the strong start to the year, Illumina bumped up its guidance. It now expects revenue between $4.52 billion and $4.62 billion, up $20 million at the midpoint versus its prior guidance. \n</p>\n<p>\n  It now forecasts adjusted per-share earnings between $5.15 and $5.30, up from $5.05 to $5.20. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Paul Ziobro at paul.ziobro@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 30, 2026 16:05 ET (20:05 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ILMN","symbol_name":"Illumina","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2632651206","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2632651206","pubTimestamp":1777579500,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Illumina posted higher profit and sales in the first quarter, citing rising demand for its gene-sequencing machines.The genomics company on Thursday reported a profit of $134 million, or 87 cents a share, compared with $131 million, or 82 cents, in the same quarter a year ago.Adjusted earnings came in at $1.15 a share. Analysts polled by Factset expected $1.05 a share.Revenue rose 4.8% to $1.09 billion, ahead of the $1.07 million expected by analysts.Chief Executive Jacob Thaysen said that demand for its NovaSeq X machine is increasing as the company helps its clinical customers expand into new application areas.With the strong start to the year, Illumina bumped up its guidance. It now expects revenue between $4.52 billion and $4.62 billion, up $20 million at the midpoint versus its prior guidance.It now forecasts adjusted per-share earnings between $5.15 and $5.30, up from $5.05 to $5.20.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ILMN":"Illumina","SOCL":"社交媒体ETF-Global X"},"translate_title":"Illumina公布第一季度利润和销售额较高，原因是对NovaSeq X的需求不断增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SOCL":1.5,"ILMN":1.5},"content_text":"By Paul Ziobro \n\n\n \n\n\nIllumina posted higher profit and sales in the first quarter, citing rising demand for its gene-sequencing machines. \n\n\n  The genomics company on Thursday reported a profit of $134 million, or 87 cents a share, compared with $131 million, or 82 cents, in the same quarter a year ago. \n\n\n  Adjusted earnings came in at $1.15 a share. Analysts polled by Factset expected $1.05 a share. \n\n\n  Revenue rose 4.8% to $1.09 billion, ahead of the $1.07 million expected by analysts. \n\n\n  Chief Executive Jacob Thaysen said that demand for its NovaSeq X machine is increasing as the company helps its clinical customers expand into new application areas. \n\n\n  With the strong start to the year, Illumina bumped up its guidance. It now expects revenue between $4.52 billion and $4.62 billion, up $20 million at the midpoint versus its prior guidance. \n\n\n  It now forecasts adjusted per-share earnings between $5.15 and $5.30, up from $5.05 to $5.20. \n\n\n \n\n\n  Write to Paul Ziobro at paul.ziobro@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2026 16:05 ET (20:05 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}